Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Athens
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Athens, GA

Studies commonly pay $75 to $4,500 per completed study

71 clinical trials are currently recruiting participants within 30 miles of Athens. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

71studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Athens right now

Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page

Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women

Sleep Quality, Compliance N/A Interventional 36 participants sought
Physical Activity Measurement Lab — Athens, Georgia (0.9 mi) · Sponsor: University of Georgia
See eligibility & contact on ClinicalTrials.gov (NCT07520786)

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

Blood Loss, Surgical N/A Interventional 40 participants sought
University Surgical Vascular — Watkinsville, Georgia (6.5 mi) · Sponsor: University Surgical Vascular
See eligibility & contact on ClinicalTrials.gov (NCT06647017)

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Locally Advanced Solid Tumors, Metastatic Solid Tumors Phase 1, Phase 2 Interventional 500 participants sought
University Cancer and Blood Center — Athens, Georgia (0.9 mi) · Sponsor: Turning Point Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT03093116)

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Relapsed or Refractory Multiple Myeloma Phase 3 Interventional 810 participants sought
Local Institution - 0211 — Athens, Georgia (0.9 mi) · Sponsor: Celgene
See eligibility & contact on ClinicalTrials.gov (NCT05519085)

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Non-small Cell Lung Cancer Phase 2 Interventional 66 participants sought
University Cancer & Blood Center (UCBC) - Athens — Athens, Georgia (0.9 mi) · Sponsor: Teligene US
See eligibility & contact on ClinicalTrials.gov (NCT06010329)

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Non Small Cell Lung Cancer, Triple Negative Breast Cancer Phase 1 Interventional 85 participants sought
University Cancer & Blood Center — Athens, Georgia (0.9 mi) · Sponsor: Compass Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06150664)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Athens, Georgia (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Atrial Fibrillation (AF), Persistant Atrial Fibrillation N/A Interventional 699 participants sought
Piedmont Athens Regional — Athens, Georgia (0.9 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07187115)

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

Prostate Cancer Phase 4 Interventional 700 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05803941)

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Phase 3 Interventional 840 participants sought
Research Site — Athens, Georgia (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06764875)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis Phase 3 Interventional 1,264 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06119581)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought
89bio Clinical Study Site — Athens, Georgia (0.9 mi) · Sponsor: 89bio, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06419374)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer Phase 3 Interventional 590 participants sought
University Cancer and Blood Center — Athens, Georgia (0.9 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06881784)

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Intestinal Neoplasms, Gastrointestinal Neoplasms Phase 3 Interventional 800 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07222800)

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 2 Interventional 99 participants sought
University Cancer & Blood Center — Athens, Georgia (0.9 mi) · Sponsor: Teligene US
See eligibility & contact on ClinicalTrials.gov (NCT05168566)

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 840 participants sought
University Cancer & Blood Cent /ID# 261824 — Athens, Georgia (0.9 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06236438)

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma Phase 2, Phase 3 Interventional 982 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06989437)

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 626 participants sought
University Cancer & Blood Center (UCBC) - Athens — Athens, Georgia (0.9 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04613596)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05334069)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile, Clostridium Difficile Infections Phase 3 Interventional 852 participants sought
Summit Clinical Research, LLC — Athens, Georgia (0.9 mi) · Sponsor: Vedanta Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06237452)

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia N/A Observational 320 participants sought
University of Georgia — Athens, Georgia (0.9 mi) · Sponsor: Beth Israel Deaconess Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06740383)
Actively enrolling

Studies you may be able to join near Athens

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Athens

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical & Translational Research Unit (CTRU)

★ 4.8
109 Bowstrom Road, Athens, GA 30606
(706) 713-2721
"Also a research participant in a study, not only were the staff experienced and knowledgeable about their field, but they were incredibly kind indivi…"
— Jacob Yoo, 5★

Athena Clinical Research

2005 Prince Ave, Athens, GA 30606
(706) 208-9700

Summit Clinical Research

★ 1.0
3320 Old Jefferson Rd Bldg.400, Athens, GA 30607
(706) 400-4262
"I was in or trying to be in a Liver study with Summit clinical I was doing everything they asked me to do. And because the owner of the facility did …"
— Robin Greenlee, 1★

Complex Carbohydrate Research Center

★ 4.8
CCRC, 315 Riverbend Rd, Athens, GA 30602
(706) 542-4401
"CCRC at the University of Georgia is an excellent research center with world-class facilities, supportive faculty, and a highly collaborative environ…"
— Bijoyananda Mishra, 5★

UGA Center for Tropical and Emerging Global Diseases (CTEGD)

500 D. W. Brooks Drive Ste 335, Athens, GA 30605
(706) 542-3688

UGA Biomechanics Lab

Ramsey Student Center, 330 River Rd Rm 103, Athens, GA 30602
(706) 542-4132

Poultry Diagnostic & Research Center

★ 5.0
953 College Station Rd, Athens, GA 30602
(706) 542-1904
"Helping keep our food supplies safe"
— Jane Cunningham, 5★

University of Georgia Office of Research

150, 500 D. W. Brooks Drive, Athens, GA 30602
(706) 542-5969

Lighthouse Neuropsychology

★ 4.7
575 Research Dr Ste B, Athens, GA 30605
(706) 850-9339
"5 stars isn't enough! My Aunt was referred by her psychologist to Lighthouse Neuropsychology. Dr. Finley was patient, warm, and so good at putting my…"
— Cheryl Ford-Jones, 5★

Clinical trials in Athens: what's recruiting

The Athens area currently has 71 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Athens, the most active research areas are:

  • Cancer & Oncology16 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Athens, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Athens

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Athens participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Athens pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Athens?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Athens safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Athens, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Athens typically complete one or two studies per year.

Paid clinical trials near Athens

Other metros within reach

Gainesville, GA152 Atlanta, GA1,693 Macon, GA73 Greenville, SC373 Mauldin, SC373 Warner Robins, GA73 Augusta, GA182 Spartanburg, SC357

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Athens Bladder Issues Due To Spinal Cord Injury in Athens All conditions

More of GA

Atlanta1,693 Augusta182 Savannah169 Gainesville152 Macon73 Warner Robins73 Columbus67

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts